393 related articles for article (PubMed ID: 18639248)
21. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.
Apte MV; Wilson JS
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():69-74. PubMed ID: 22320920
[TBL] [Abstract][Full Text] [Related]
22. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
23. Tumor-stromal interactions in pancreatic cancer.
Tod J; Jenei V; Thomas G; Fine D
Pancreatology; 2013; 13(1):1-7. PubMed ID: 23395563
[TBL] [Abstract][Full Text] [Related]
24. Hyperglycemia promotes the perineural invasion in pancreatic cancer.
Li J; Ma Q
Med Hypotheses; 2008 Sep; 71(3):386-9. PubMed ID: 18571873
[TBL] [Abstract][Full Text] [Related]
25. The acellular fraction of stored platelets promotes tumor cell invasion.
Dineen SP; Roland CL; Toombs JE; Kelher M; Silliman CC; Brekken RA; Barnett CC
J Surg Res; 2009 May; 153(1):132-7. PubMed ID: 18541268
[TBL] [Abstract][Full Text] [Related]
26. Does alpha-methylacyl-CoA-racemase play an important role in perineural tumor invasion?
Sen Gupta R
Hum Pathol; 2007 Aug; 38(8):1289-90; author reply 1290-1. PubMed ID: 17640555
[No Abstract] [Full Text] [Related]
27. Paucicellular infiltrating ductal carcinoma of pancreas: an unusual variant.
Fagih M; Serra S; Chetty R
Ann Diagn Pathol; 2007 Feb; 11(1):46-8. PubMed ID: 17240307
[TBL] [Abstract][Full Text] [Related]
28. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
[TBL] [Abstract][Full Text] [Related]
29. The integrin-extracellular matrix axis in pancreatic cancer.
Grzesiak JJ; Ho JC; Moossa AR; Bouvet M
Pancreas; 2007 Nov; 35(4):293-301. PubMed ID: 18090233
[TBL] [Abstract][Full Text] [Related]
30. Tumor-stroma interactions: their role in the control of tumor cell invasion.
Zigrino P; Löffek S; Mauch C
Biochimie; 2005; 87(3-4):321-8. PubMed ID: 15781319
[TBL] [Abstract][Full Text] [Related]
31. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
[TBL] [Abstract][Full Text] [Related]
32. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.
Kadaba R; Birke H; Wang J; Hooper S; Andl CD; Di Maggio F; Soylu E; Ghallab M; Bor D; Froeling FE; Bhattacharya S; Rustgi AK; Sahai E; Chelala C; Sasieni P; Kocher HM
J Pathol; 2013 May; 230(1):107-17. PubMed ID: 23359139
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases.
Ceyhan GO; Bergmann F; Kadihasanoglu M; Altintas B; Demir IE; Hinz U; Müller MW; Giese T; Büchler MW; Giese NA; Friess H
Gastroenterology; 2009 Jan; 136(1):177-186.e1. PubMed ID: 18992743
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic stellate cells promotes the perineural invasion in pancreatic cancer.
Zhou Y; Zhou Q; Chen R
Med Hypotheses; 2012 Jun; 78(6):811-3. PubMed ID: 22513235
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance.
Vonlaufen A; Phillips PA; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
Cancer Res; 2008 Oct; 68(19):7707-10. PubMed ID: 18829522
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
37. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
[TBL] [Abstract][Full Text] [Related]
38. Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values.
Feurino LW; Fisher WE; Bharadwaj U; Yao Q; Chen C; Li M
Cancer Invest; 2006 Nov; 24(7):696-703. PubMed ID: 17118780
[TBL] [Abstract][Full Text] [Related]
39. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
[TBL] [Abstract][Full Text] [Related]
40. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
